Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction

American Heart Journal

Volumn 143, Issue 6, 2002, Pages 1040-1045

  Jeremias, Allen ^a   Albirini, Abdulhay ^a   Ziada, Khaled M ^a   Chew, Derek P ^a   Brener, Sorin J ^a   Topol, Eric J ^a   Ellis, Stephen G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0036089003     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.122124     Document Type: Article

References (32)

1. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention
2. Minimal myocardial damage during coronary intervention is associated with impaired outcome
3. Long-term clinical events after creatine kinase - Myocardial band isoenzyme elevation after successful coronary stenting
4. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention
5. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting
6. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coranary interventions
7. Increased risk of non-Q-wave myocardial infarction after directional atherectomy is platelet dependent: Evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic Complications
8. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study
9. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
10. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: Benefit is extended to improvement in intermediate-term survival
11. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
12. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
13. Morbidity and mortality of renal dialysis: An NIH consensus conference statement
14. Risks associated with renal dysfunction in patients in the coronary care unit
15. Recommended method far the determination of creatine kinase in blood modified by the inclusion of EDTA
16. Prognostic implication of creatine kinase elevation following elective coronary artery interventions
17. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: Intravascular ultrasound study of 2256 patients
18. Recognition of the importance of embolization in atherosclerotic vascular disease
19. Coronary microembolization
20. Myonecrosis after revascularization procedures
21. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
22. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial
23. Diagnostic value of creatine kinase and creatine kinase MB isoenzyme in chronic hemodialysis patients: A longitudinal study
24. Cardiac troponin I: A marker with high specificity for cardiac injury
25. Cardiac troponin T predicts mortality in patients with end-stage renal disease
26. The European (European Dialysis and Transplantation Association - European Renal Association) Registry
27. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients
28. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients
29. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients
30. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?
31. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
32. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation